Literature DB >> 30797217

Formation of intracranial de novo aneurysms and recurrence after neck clipping: a systematic review and meta-analysis.

Alexander Spiessberger1, Deborah R Vogt2, Javier Fandino1, Serge Marbacher1.   

Abstract

OBJECTIVE: Incidence rates of de novo aneurysm formation and recurrence after clip ligation remain controversial. In this meta-analysis, the authors provide data on pooled annual incidence rates and the association of patient characteristics with time to formation of de novo aneurysms and time to recurrence after clipping.
METHODS: A search of the literature up to June 15, 2016, on PubMed and a systematic review were performed. The association of age, aneurysm rupture status, aneurysm multiplicity, and anatomical location with time to recurrence or formation of de novo aneurysm was estimated using multivariable Cox proportional-hazards models. Kaplan-Meier estimates (event-free survival curves) are shown. Pooled annualized incidence rates of recurrent and de novo aneurysms were estimated using Poisson regression. Proportions of aneurysms and average follow-up times are displayed as bubble plots with LOESS smoothers weighted for study size.
RESULTS: Of the 7606 articles screened, 92 were included in the study. Case reports on 101 patients with recurrent aneurysms and 132 patients with de novo aneurysms were analyzed. Long-term follow-up studies on de novo aneurysm formation included 13,723 patients with 101,378 patient-years of follow-up; studies on aneurysm recurrence included 5922 patients with 31,055 patient-years of follow-up. Mean time to recurrence was 12.9 ± 6.6 years (mean ± standard deviation), and mean time to de novo formation was 9.3 ± 6.1 years. No association with sex, aneurysm location, and initial rupture could be shown. De novo aneurysms occurred later in patients with multiplicity of aneurysms at diagnosis (HR 0.63, p = 0.03) and in patients with increasing age (HR per 10 yrs 0.88, p = 0.06). Pooled annualized incidence rates were 0.35% for de novo aneurysms and 0.13% for recurrent aneurysms.
CONCLUSIONS: Despite low reported annual incidence rates, the cumulative risk of 9.6%-22% for aneurysm recurrence or de novo formation 20 years after clip ligation warrants lifelong follow-up. Screening at 5, 10, and 20 years would detect 30.8% (95% CI 23.3%-37.6%), 64.2% (95% CI 55.9%-70.9%), and 95.9% (95% CI 90.9%-97.9%) of de novo aneurysms. Screening for recurrent aneurysms at 10, 15, and 20 years would detect 36.6% (95% CI 26.5%-45.4%), 65.3% (95% CI 54.7%-73.5%), and 95.1% (95% CI 85.8%-96.6%) of lesions.

Entities:  

Keywords:  IA = intracranial aneurysm; SAH = subarachnoid hemorrhage; de novo aneurysms; recurrent aneurysms; vascular disorders

Year:  2019        PMID: 30797217     DOI: 10.3171/2018.10.JNS181281

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  5 in total

1.  Incidence rate and predictors of recurrent aneurysms after clipping: long-term follow-up study of survivors of subarachnoid hemorrhage.

Authors:  Hyun Jin Han; Woosung Lee; Junhyung Kim; Keun Young Park; Sang Kyu Park; Joonho Chung; Yong Bae Kim
Journal:  Neurosurg Rev       Date:  2022-06-23       Impact factor: 2.800

2.  Rabbit Elastase Aneurysm Model Mimics the Recurrence Rate of Human Intracranial Aneurysms following Platinum Coil Embolization.

Authors:  Y-H Ding; S Ghozy; D Dai; W Brinjikji; D F Kallmes; R Kadirvel
Journal:  AJNR Am J Neuroradiol       Date:  2022-04-28       Impact factor: 4.966

3.  Repeated Aneurysm Intervention.

Authors:  Vladimír Beneš; Anna Štekláčová; Ondřej Bradáč
Journal:  Adv Tech Stand Neurosurg       Date:  2022

4.  Formation and Schema Analysis of Oil Painting Style Based on Texture and Color Texture Features under Few Shot.

Authors:  Yuanyuan Zhao
Journal:  Comput Intell Neurosci       Date:  2022-06-13

5.  LATE ANEURYSM RELAPSE AFTER MICROSURGICAL TREATMENT OF MIDDLE CEREBRAL ARTERY ANEURYSM: A CASE REPORT AND LITERATURE REVIEW OF TREATMENT OPTIONS.

Authors:  Krešimir Rotim; Marina Raguž; Ante Rotim; Bruno Splavski; Vladimir Kalousek
Journal:  Acta Clin Croat       Date:  2020-09       Impact factor: 0.780

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.